LL-37 (Human Cathelicidin Antimicrobial Peptide)
Research-Grade Host Defense Peptide
Tagline: Innate Immunity & Wound Healing Research
Product Description
LL-37 is the only known human cathelicidin-derived antimicrobial peptide, consisting of 37 amino acids. It is a key effector molecule of the innate immune system, with potent broad-spectrum antimicrobial activity against bacteria, viruses, and fungi, as well as immunomodulatory properties.
Researchers use LL-37 in preclinical studies to explore host-pathogen interactions, epithelial barrier defense, wound healing, and inflammatory signaling pathways. Its dual role as an antimicrobial agent and immune modulator makes it an essential tool in infectious disease, dermatology, and immunology research.
For Laboratory and Scientific Research Use Only. Not for Human Consumption.
Why Researchers Choose LL-37
-
Broad-Spectrum Antimicrobial: Effective against Gram-positive and Gram-negative bacteria, fungi, and some viruses.
-
Immunomodulatory Activity: Regulates cytokine production and modulates inflammation.
-
Barrier Function Support: Promotes epithelial cell migration and wound closure in models.
-
Endogenous Relevance: Derived from human cathelicidin (hCAP18), providing physiological translational value.
-
Batch Verified: ≥98% purity confirmed by HPLC and mass spectrometry for reproducibility.
Important Note
For laboratory and scientific research only. Not for human consumption, therapeutic, or diagnostic use.
